Drug General Information (ID: DDID027G3V)
  Drug Name Atenolol Drug Info Methoxyflurane Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antihypertensive Agents Anesthetics
  Structure

 Mechanism of Atenolol-Methoxyflurane Interaction (Severity Level: Moderate)
     Additive hypertensive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Atenolol Methoxyflurane
      Mechanism Hypertensive effects Hypertensive effects
      Key Mechanism Factor 1
Factor Name Hypertensive effects
Factor Description Hypertension is defined as a blood pressure reading above a prescribed limit (130/90 mmHg). Most people with hypertension have no signs or symptoms; others may experience: severe headache, shortness of breath, nosebleeds, severe anxiety, and feeling a tingling sensation in the neck or head.
      Mechanism Description
  • Additive hypertensive effects by the combination of Atenolol and Methoxyflurane 

Recommended Action
      Management Caution is recommended when cardiac depressant anesthetics are used in patients taking beta blockers. Newer inhalation anaesthetics are generally considered safer. Withdrawing beta-blocker therapy before surgery is not recommended in most patients.

References
1 Product Information. Tenormin (atenolol). ICN Pharmaceuticals Inc, Cost Mesa, CA.
2 Lilja JJ, Raaska K, Neuvonen PJ "Effects of orange juice on the pharmacokinetics of atenolol." Eur J Clin Pharmacol (2005):